eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Review: could Wellbutrin cause Neuroleptic malignant syndrome?

Summary: Neuroleptic malignant syndrome is found among people who take Wellbutrin, especially for people who are female, 60+ old, have been taking the drug for < 1 month, also take medication Seroquel, and have Depression.

We study 49,344 people who have side effects while taking Wellbutrin from FDA and social media. Among them, 84 have Neuroleptic malignant syndrome. Find out below who they are, when they have Neuroleptic malignant syndrome and more.

You are not alone: join a support group for people who take Wellbutrin and have Neuroleptic malignant syndrome >>>

 

Wellbutrin

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. (latest outcomes from 55,089 Wellbutrin users)

Neuroleptic malignant syndrome

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents) has been reported by people with schizophrenia, depression, bipolar disorder, psychotic disorder, parkinson's disease. (latest reports from 7,507 Neuroleptic malignant syndrome patients)

On Mar, 31, 2015: 49,335 people reported to have side effects when taking Wellbutrin. Among them, 84 people (0.17%) have Neuroleptic Malignant Syndrome.

Trend of Neuroleptic malignant syndrome in Wellbutrin reports

Time on Wellbutrin when people have Neuroleptic malignant syndrome * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years
Neuroleptic malignant syndrome100.00%0.00%0.00%0.00%0.00%0.00%0.00%

Age of people who have Neuroleptic malignant syndrome when taking Wellbutrin * :

0-12-910-1920-2930-3940-4950-5960+
Neuroleptic malignant syndrome4.55%0.00%4.55%7.58%19.70%21.21%21.21%21.21%

Severity of Neuroleptic malignant syndrome when taking Wellbutrin ** :

n/a

How people recovered from Neuroleptic malignant syndrome ** :

n/a

Top conditions involved for these people * :

  1. Depression (20 people, 23.81%)
  2. Bipolar disorder (14 people, 16.67%)
  3. Schizophrenia (13 people, 15.48%)
  4. Sleep disorder (8 people, 9.52%)
  5. Agitation (5 people, 5.95%)

Top co-used drugs for these people * :

  1. Seroquel (37 people, 44.05%)
  2. Risperdal (25 people, 29.76%)
  3. Zyprexa (24 people, 28.57%)
  4. Depakote (15 people, 17.86%)
  5. Lexapro (15 people, 17.86%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of wellbutrin and neuroleptic malignant syndrome on

Do you have Neuroleptic Malignant Syndrome while taking Wellbutrin?

 

 

 

You are not alone! Join a support group on :
- support group for people who take Wellbutrin and have Neuroleptic Malignant Syndrome
- support group for people who take Wellbutrin
- support group for people who have Neuroleptic Malignant Syndrome

Drugs in real world that are associated with:

Could your condition cause:

Recent related drug studies (Check your drugs):

Recent Wellbutrin related drug comparison:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.